The epithelial-mesenchymal transition (EMT) plays a central role in cancer metastasis and drug resistance -two persistent clinical challenges. Epithelial cells can undergo a partial or full EMT, attaining either a hybrid epithelial/mesenchymal (E/M) or mesenchymal phenotype, respectively. Recent studies have emphasized that hybrid E/M cells may be more aggressive than their mesenchymal counterparts. However, mechanisms driving hybrid E/M phenotypes remain largely elusive. Here, to better characterize the hybrid E/M phenotype(s) and tumor aggressiveness, we integrate two computational methods -(a) RACIPE -to identify the robust gene expression patterns emerging from the dynamics of a given gene regulatory network, and (b) EMT scoring metric -to calculate the probability that a given gene expression profile displays a hybrid E/M phenotype. We apply the EMT scoring metric to RACIPE-generated gene expression data generated from a core EMT regulatory network and classify the gene expression profiles into relevant categories (epithelial, hybrid E/M, mesenchymal). This categorization is broadly consistent with hierarchical clustering readouts of RACIPE-generated gene expression data. We show that the EMT scoring metric can be used to distinguish between samples composed of exclusively hybrid E/M cells and those containing mixtures of epithelial and mesenchymal subpopulations using the RACIPE-generated gene expression data.
Introduction
The epithelial-mesenchymal transition (EMT) is a trans-differentiation developmental program by which epithelial (E) cells weaken their adhesive bonds with neighbors as well as apico-basal polarity, while concomitantly gaining mesenchymal (M) traits of migration and/or invasion [1, 2] . Cancer cells undergoing EMT typically have enhanced metastatic abilities [2, 3] , elevated resistance against chemotherapy [4, 5] and can evade the immune system [6] , thus accelerating malignancy. In the developmental context of mammary morphogenesis and the physiological context of wound healing, cells rarely undergo a complete EMT.
Instead, they exhibit a transient hybrid epithelial/mesenchymal (E/M) phenotype that shows a mixture of traits -epithelial traits of cell-cell adhesion, and mesenchymal traits of migration [3] . Thus, the hybrid E/M phenotype facilitates collective cell migration, instead of individual cell migration -a characteristic of cells having undergone a complete EMT. This concept has recently gained momentum in the context of cancer metastasis, wherein it has been observed that malignant cells can maintain a hybrid E/M phenotype and migrate collectively, eventually appearing in the blood as clusters of circulating tumor cells (CTCs) [7] [8] [9] [10] .
Moreover, these CTC clusters, often five to eight cells in size, contribute much more than their proportional share to metastases [11] , thus behaving as 'chief instigators' of metastasis. Cells in these clusters often display a hybrid E/M phenotype [9, 10, 12] , and can resist cell death in circulation by evading immune attacks and providing survival signals to one another through their cell-cell contacts [12] . Therefore, hybrid E/M cells may occupy the 'metastatic sweet spot' [13, 14] .
The hybrid E/M phenotype has been tacitly assumed to be 'metastable' or transient [15, 16] , but recent computational studies suggest that the hybrid E/M phenotype can be a stable cell phenotype, particularly in the presence of 'phenotypic stability factors' (PSFs) such as the transcription factors GRHL2, OVOL2, NUMB and ∆Np63α [10, [17] [18] [19] [20] [21] [22] . Resonating with predictions of these computational models, non-small cell lung cancer (NSCLC) cells H1975 have been shown to stably (i.e. over multiple passages) co-express epithelial and mesenchymal markers -E-cadherin and vimentin -at a single-cell level in vitro [19] .
Consistent with predictions from mathematical models, knockdown of GRHL2, OVOL2 or NUMB in H1975 cells results in a complete EMT [18, 19, 22] . Overall, these studies have supported the relevance of a stable hybrid E/M phenotype and PSFs along with their implications for both mammary morphogenesis and cancer metastasis [12] .
EMT is orchestrated by complex gene regulatory networks (GRNs) that involve microRNAs (miRs), transcription factors (TFs), alternative splicing mechanisms, and epigenetic modifications [23, 24] .
Particularly, members of the miR-200 and the miR-34 family can maintain or induce epithelial features, and TFs such as ZEB1/2, SNAI1/2 and FOXC2 can trigger the transition toward a mesenchymal phenotype.
Moreover, these regulators exhibit extensive crosstalk, forming multiple feedback loops [23] . Mathematical modeling approaches have been used to analyze the dynamics of EMT regulatory networks [17, [25] [26] [27] [28] [29] [30] [31] .
However, most of these studies consider interactions among only a small number of genes regulating EMT, because a quantitative simulation of the GRN dynamics is difficult owing to insufficient knowledge of kinetic parameter values, particularly when the network size is large.
Recently, we developed a computational method, random circuit perturbation (RACIPE), to interrogate the robust dynamical features of GRNs without the need for precise parameter values [32, 33] . RACIPE generates an unbiased ensemble of mathematical models based on the topological information (i.e. genes and interactions) of a GRN. Each model is characterized by a unique set of parameters that are randomly sampled within ranges of values that are biologically relevant, and then numerically solved. The stable state solutions of the ensemble models are collected and analyzed, through which the most significant gene expression patterns associated with a specific GRN are extracted. In this framework, variability among different sets of parameters generated by RACIPE captures both the heterogeneity among individual cells and the effects of different input signals to the GRN. Thus, the RACIPE-generated stable state solutions can, in principle, represent the gene expression patterns of diverse individual cell phenotypes in multiple contexts. Here, we apply RACIPE to EMT regulatory networks to generate in silico gene expression data of different EMT phenotypes.
Separately, the lack of a rigorous quantitative definition of a hybrid E/M phenotype motivated us to develop a statistical learning method, the EMT scoring metric [34] . This approach assigns a probability of membership in the hybrid E/M category, given the gene expression data of a sample. It also assigns each sample a corresponding EMT score on a scale from 0 (fully epithelial) to 2 (fully mesenchymal) with an intermediate score of 1 representing maximally hybrid E/M signatures. This approach, when applied to the NCI-60 human tumor cell line gene expression dataset as the training set, identified claudin-7 (CLDN7) and the ratio of vimentin to E-cadherin (VIM/CDH1) as the best-fit pair of predictors to categorize the EMT phenotypes. The algorithm has been accurate in characterizing the EMT status of multiple cancer cell lines and has elucidated a subtype-specific association between the EMT status and patient survival.
Here, we use RACIPE to test the ability of our EMT scoring metric to quantify the EMT phenotypes. We first apply RACIPE on a proposed core EMT regulatory network, containing 26 genes and 100 regulatory links ( Fig. 1a ) and use the hierarchical clustering analysis (HCA) to classify the RACIPE-generated gene expression data into four main clusters corresponding to one epithelial, one mesenchymal, and two hybrid E/M (E/M I and II) phenotypes. We show that the EMT scoring metric can accurately recapitulate the EMT status of RACIPE-generated hybrid E/M samples. We next construct in silico mixtures of RACIPE-generated E, M and E/M II samples in various ratios. We present a proof-of-principle for distinguishing samples containing individual hybrid E/M cells from those containing mixtures of E and M cells by applying an extension of our EMT scoring metric. We demonstrate that the EMT metric approach can accurately identify the proportions of the different subpopulations for all the various combinations of mixtures studied here. This new method is enabled by having samples generated from RACIPE projected on to the EMT scoring metric space. Finally we validate the proposed method comparing its prediction to data from multiple non-small cell lung cancer (NSCLC) cell lines.
Materials and Methods

Generation of EMT gene expression data by RACIPE
The EMT regulatory network ( Fig. 1a) we consider here contains 26 gene products and 100 regulatory links, the majority of which are transcriptional in nature. There are also microRNA-mediated translational regulation. All links in the network considered here are modeled by shifted Hill functions [25] . RACIPE takes the topological information of the EMT regulatory network as the input and generates multiple mathematical models.
The general rate equation representing the temporal dynamics for a single gene is of the form: The temporal dynamics of all 26 nodes of the EMT regulatory network are characterized by the above functional form. In the RACIPE framework, mathematical model refers to a specific choice of parameters, and many models are created. We typically use 10,000 to 100,000 models. For each model, the parameters are randomly sampled within biologically reasonable ranges. The sampled parameters satisfy the 'halffunctional' rule [32] so that each regulatory link has an equal chance (~50%) to be active or inactive. For generating each mathematical model, 200 initial conditions are used to numerically integrate the dynamical equations using Euler's Method and we keep all simulations for which the system reaches steady state on the chosen integration interval. Depending on the specific parameters, a single model may give rise to one or more stable steady state solutions dependent upon the model's initial conditions. The stable steady state solutions from all models are analyzed via the EMT scoring metric.
EMT scoring metric
In this approach, statistical models are created to resolve training samples into their a priori known categories. EMT scoring is performed by applying the best-fit model obtained from an iterative statistical procedure developed previously to relevant gene expression samples [34] . This best fit model was found to maximally resolve the NCI-60 cell line gene expression dataset (GSE5846) based on E, M, or hybrid E/M phenotype using ordinal multinomial logistic regression. The (log2-normalized) input predictors include the ratio of vimentin and E-cadherin (VIM/CDH1) and claudin 7 (CLDN7). Model output for a given sample, S, is given by
This ordered triplet is interpreted as the probability that sample S falls into either of the following three 2] with the ordering < < . In particular,
The metric represents epithelial samples in the range 0 ≤ < 0.5 , hybrid for 0.5 ≤ ≤ 1.5 , and mesenchymal for 1.5 < ≤ 2.
Generating the mixtures of E, M and hybrid E/M II samples
We of EMT presented here is an extended version of the one used in our previous study [32] . Specifically, three
Predictions of the mixture proportions
Results
Construction of the regulatory network of EMT
proposed PSFs, OVOL2, GRHL2 and ∆Np63α, together with CLDN7 are included due to their identified roles in epithelial-mesenchymal plasticity (See SI Section 1 and Table S1 for more information).
RACIPE identifies the gene expression patterns of multiple EMT phenotypes
We apply RACIPE to the core gene regulatory network above ( Fig. 1a ) and collect the gene expression data from 10,000 different sets of parameters (10,000 distinct RACIPE models). Hierarchical clustering analysis, used to analyze the gene expression patterns of RACIPE-generated data, reveals four large clusters ( Fig. 1b) . The first cluster is characterized by high expression of epithelial-associated genes or microRNAs, 
The EMT scoring metric captures the hybrid E/M I and II signatures generated by RACIPE
The heterogeneity of RACIPE-generated aggregate output may be appreciated by projection of these samples onto the two-dimensional EMT metric predictor space ( Fig. 2a) . This space is divided into three Our findings highlight the consistency between RACIPE-generated gene expression samples for hybrid E/M phenotypes and their expected location on the EMT spectrum as generated by our predictive metric.
The mean signature of mesenchymal samples is also captured by the EMT metric with a 0.71 probability of being binned as mesenchymal, and a high EMT score of = 1.71. (Fig. 2b) . However, the mean signature of epithelial samples has a slightly higher probability of being binned as hybrid E/M ( U = 0.59)
as compared to epithelial ( T = 0.41) with an EMT score of = 0.59. This deviation is likely to be due to the underlying high variance of gene expression data generated by RACIPE. Nonetheless, the EMT metric has shown a consistent characterization results of the RACIPE-generated samples for the hybrid E/M I, II and M categories. We also find that the mean hybrid E/M I signature is close to that of epithelial samples, while the mean hybrid E/M II signature localizes closer to that of mesenchymal samples in the predictor space ( Fig. 2b) , which is consistent with the clustering results observed in Fig. 1b . Interestingly, the hybrid E/M II samples have similar mean VIM/CDH1 levels as that of epithelial samples and similar mean CLDN7 levels as that of mesenchymal samples, thus sharing features of both epithelial and mesenchymal signatures ( Fig. 2b) . This observation is reminiscent of a recent study showing that overexpression of miR-200 in mesenchymal subpopulation of HMLE cells induced only a partial EMT -the mesenchymal score of these cells did not change upon miR-200 overexpression, but the epithelial score increased [38] . three independent replicates were generated, and they showed highly reproducible behavior (Fig. 4) (Fig. 4a, d) . Similarly, the EMT metric- (Fig. 3b, d) . Motivated by the initial observation that the mean RACIPE-generated epithelial signature was binned as hybrid E/M, we further analyzed whether a mixture model constructed on samples binned as epithelial by the EMT metric would lead to significantly different results. We performed sample purification and isolated the purified epithelial samples that exhibit high expression of multiple E markers including CDH1, GRHL2, OVOL2, ∆Np63α and CLDN7. All of these players are known to be key regulators of epithelial phenotype [39] [40] [41] [42] . Similarly, we performed sample purification to isolate the purified mesenchymal samples that have high expression of multiple M markers, including VIM, ZEB1, ZEB2, TGF-β and FOXC2. These markers are experimentally known as key inducers of the mesenchymal phenotype [26, 43] . This step is the in silico analogue to flow cytometric sorting of E (and M) samples for a more robust characterization of these two cell states, as captured by the increased accuracy of EMT metric in categorizing these samples (Tables S2, S3 ). The purified epithelial and mesenchymal samples are accurately predicted via EMT metric ( T = 0.82, = 0.18 and V = 0.88, = 1.88, respectively), and visually fall well within their respective domains of predictor space (Fig. S1, See SI sections 2-3 for more details) . Mixtures containing purified E and M samples for five different ratios were synthesized and analyzed by the EMT metric. Similar to the case with 'unpurified' samples (i.e. using all E samples), the EMT metric accurately predicts the proportions of the mixtures of 'purified' E and M samples (Fig. S2) . In short, the sample purification analysis here was only to offer alternative reference points for E and M signatures which might be more representative of real biological samples.
Using the EMT scoring metric to distinguish between samples comprised of individual hybrid E/M cells and samples that are mixtures of E and M cells
The EMT scoring metric can accurately resolve mixtures of hybrid E/M, E and M phenotypes when E and M phenotypes have the same proportions
As with five different ratios were randomly selected in triplicate and were highly reproducible and resolvable ( Fig. 4) 40%, 20%], respectively ( Fig. 3) . These results lead to the hypothesis that samples dominated by the hybrid E/M II phenotype tend to localize far from the 'mixture curve', while samples locating close to the 'mixture curve' are possible mixtures of E and M cells.
Using the EMT scoring metric to characterize the EMT proportions of NSCLC cell lines
To test the hypothesis that samples dominated by the hybrid E/M phenotype localize far from the 'mixture curve', we performed experiments in multiple NSCLC cell lines that have been categorized as epithelial, mesenchymal, or hybrid E/M based on bulk proteomic measurements (GSE63882) [36] . The EMT scoring metric characterizes H1568 cell line as largely epithelial, H1792 cell line as largely mesenchymal, and the H920, H1944, H2228 and HCC2279 cell lines as hybrid E/M (Fig. 5a) . Among the hybrid E/M cell lines, H920 and H2228 locate far from the 'mixture curve' in the EMT metric predictor space, thus being predicted to contain a large proportion of the hybrid E/M cells, while H1944 and HCC2279 cell lines lie on/close to the curve, which means that they are possible mixtures of E and M cells.
To validate this prediction, we conduct single-cell immunofluorescence experiments to analyze the presence of canonical epithelial and mesenchymal markers -E-cadherin and vimentin -in these cell lines.
H1568 cells largely stain for E-cadherin, with only a few cells staining for vimentin, thus depicting a predominantly epithelial phenotype. Conversely, H1792 cells express only vimentin, and very low Ecadherin, exhibiting a predominantly mesenchymal phenotype (Fig. 5b) . Most cells in H920 and H2228 tend to co-express E-cadherin and vimentin and some cells express only E-cadherin, thus demonstrating a mixture of hybrid E/M and epithelial cells, with a hybrid E/M phenotype being the dominant subpopulation ( Fig. 5b) . 
Discussion
The existence and characterization of one or more hybrid epithelial/mesenchymal (E/M) phenotypes accessible during the epithelial-mesenchymal transition has generated recent attention due to their association with high metastatic potential and cancer stemness [35, [44] [45] [46] . Increasing evidence suggests that cancer cells may acquire a spectrum of hybrid E/M phenotypes, characterized by varying extents of epithelial and mesenchymal traits [35] . Thus, a rigorous characterization of the EMT status of tumors, especially the probability that a given sample is hybrid E/M-like, may contain significant prognostic value and may hold avenues for better targeted therapeutic developments [47] .
Recent years have seen a surge in various computational and experimental approaches to quantitatively characterize various aspects of EMT, including characterization of hybrid E/M phenotypes [17] [18] [19] [20] [21] 25, 26, [27] [28] [29] 35, 36, 44, 45] . Here, we test our EMT scoring metric by applying it to the in silico gene expression data generated by RACIPE. We show that the hybrid E/M II phenotype is effectively distinguished from mixtures of E and M samples, based on their different localizations in the predictor space generated by the EMT scoring metric. As compared to another EMT scoring method that requires data of the entire transcriptome [48] , our approach presented here can quantify a sample's 'EMT-ness' using a very small set of predictors with reasonable categorization results.
Our results presented here may suffer from multiple limitations. First, the EMT regulatory network constructed here, although based on extensive literature search, is in no way complete. For the purpose of computational cost, we focused on a conserved network implicated in EMT in multiple contexts. However, there may be crucial connections that we have inadvertently missed. Second, we simulated both transcriptional factors and microRNA-dependent mechanisms via the shifted Hill function formulation, while their detailed dynamics may be quite different [25] . That means we must determine the EMT status of RACIPE models only by the "expression" data as opposed to using protein concentration and/or actual cell shape and behaviors. It is worth noting that EMT is a multi-dimensional process including changes in not only gene expression, but also in many biophysical properties such as cell polarity [49] . Thus, future studies should identify biophysical features that, when combined with gene expression patterns, might provide further refinement in resolving hybrid E/M phenotypes. Third, the training dataset used for EMT scoring metric are bulk-cell gene expression profiles of 59 cancer cell lines, and 37 out of the 59 are mesenchymal [50] . Further detailed experimental characterization of the EMT phenotype at a single-cell level [51] can help expand the training dataset and perhaps increase the sensitivity, specificity and accuracy in quantifying the EMT spectrum. Despite these weaknesses, we feel that we have succeeded in showing broad consistency between the RACIPE and the EMT scoring metric and also generated a test for the existence of single cell hybrids.
The ability to fully distinguish between mixtures of E and M cells and purely hybrid E/M samples remains a relevant challenge as both of these share a common hybrid gene expression pattern on the population level. By projecting the mixtures and purely hybrid E/M cells into the predictor space of the EMT metric, we find that the mixtures of epithelial and mesenchymal tend to cluster along the convex curve adjoining purely epithelial and purely mesenchymal while samples containing purely hybrid E/M cells are not necessarily restricted to the mixture curve between unmixed epithelial and mesenchymal samples, as shown in Figs. 3 and 4 . Based on this observation, we speculate that hybrid E/M cells and mixtures of epithelial and mesenchymal cells may often be distinguishable. Gene expression data of more cell lines with a wellcharacterized EMT status, i.e. purely epithelial, mesenchymal, hybrid E/M or mixtures of well-known proportions of these phenotypes, can be used to test this hypothesis.
